T10	B-Entity	0	11	Interleukin	Interleukin	B-NP	NN	B-protein	4	NMOD	B-protein
T10	I-Entity	11	12	-	-	I-NP	HYPH	I-protein	4	NMOD	I-protein
T10	I-Entity	12	14	12	12	I-NP	CD	I-protein	4	NMOD	I-protein
O	O	15	25	expression	expression	I-NP	NN	O	0	ROOT	O
O	O	26	28	in	in	B-PP	IN	O	4	NMOD	O
O	O	29	30	B	B	B-NP	NN	B-cell_type	7	NMOD	B-cell_type
O	O	31	36	cells	cell	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	37	39	by	by	B-PP	IN	O	4	NMOD	O
O	O	40	54	transformation	transformation	B-NP	NN	O	8	PMOD	O
O	O	55	59	with	with	B-PP	IN	O	9	NMOD	O
O	O	60	67	Epstein	Epstein	B-NP	NNP	O	13	NMOD	O
O	O	67	68	-	-	I-NP	HYPH	O	13	P	O
O	O	68	72	Barr	Barr	I-NP	NNP	O	14	NMOD	O
O	O	73	78	virus	virus	I-NP	NN	O	10	PMOD	O
O	O	78	79	.	.	O	.	O	4	P	O

O	O	81	89	Although	Although	B-SBAR	IN	O	42	VMOD	O
T11	B-Entity	90	101	interleukin	interleukin	B-NP	NN	B-protein	4	NMOD	B-protein
T11	I-Entity	102	103	(	(	O	(	I-protein	4	NMOD	I-protein
T11	I-Entity	103	105	IL	IL	B-NP	NN	I-protein	8	SUB	I-protein
T11	I-Entity	105	106	)	)	O	)	I-protein	4	NMOD	I-protein
T11	I-Entity	106	107	-	-	B-NP	HYPH	I-protein	4	NMOD	I-protein
T11	I-Entity	107	109	12	12	I-NP	CD	I-protein	4	NMOD	I-protein
O	O	110	113	was	be	B-VP	VBD	O	1	SBAR	O
O	O	114	124	originally	originally	I-VP	RB	O	8	VMOD	O
O	O	125	133	purified	purify	I-VP	VBN	O	8	VC	O
O	O	134	138	from	from	B-PP	IN	O	10	VMOD	O
O	O	139	141	an	an	B-NP	DT	O	23	NMOD	O
O	O	142	149	Epstein	Epstein	I-NP	NNP	B-cell_line	15	NMOD	B-cell_line
O	O	149	150	-	-	I-NP	HYPH	I-cell_line	15	P	I-cell_line
O	O	150	154	Barr	Barr	I-NP	NNP	I-cell_line	23	NMOD	I-cell_line
O	O	155	156	(	(	O	(	I-cell_line	18	DEP	I-cell_line
O	O	156	159	EBV	EBV	B-NP	NN	I-cell_line	18	DEP	I-cell_line
O	O	159	160	)	)	O	)	I-cell_line	15	NMOD	I-cell_line
O	O	160	161	-	-	B-VP	HYPH	I-cell_line	23	NMOD	I-cell_line
O	O	161	172	transformed	transform	B-NP	VBN	I-cell_line	23	NMOD	I-cell_line
O	O	173	174	B	B	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	175	179	cell	cell	I-NP	NN	I-cell_line	23	NMOD	I-cell_line
O	O	180	184	line	line	I-NP	NN	I-cell_line	27	NMOD	I-cell_line
O	O	185	188	and	and	O	CC	O	27	NMOD	O
O	O	189	192	the	the	B-NP	DT	O	27	NMOD	O
O	O	193	197	high	high	I-NP	JJ	O	27	NMOD	O
O	O	198	209	correlation	correlation	I-NP	NN	O	11	PMOD	O
O	O	210	212	of	of	B-PP	IN	O	27	NMOD	O
O	O	213	216	EBV	EBV	B-NP	NN	O	30	NMOD	O
O	O	217	226	infection	infection	I-NP	NN	O	35	NMOD	O
O	O	227	230	and	and	I-NP	CC	O	35	NMOD	O
T12	B-Entity	231	233	IL	IL	I-NP	NN	B-protein	35	NMOD	B-protein
T12	I-Entity	233	234	-	-	O	HYPH	I-protein	35	NMOD	I-protein
T12	I-Entity	234	236	12	12	B-NP	CD	I-protein	35	NMOD	I-protein
O	O	237	247	expression	expression	I-NP	NN	O	28	PMOD	O
O	O	248	251	has	have	B-VP	VBZ	O	1	SBAR	O
O	O	252	256	been	be	I-VP	VBN	O	36	VC	O
O	O	257	266	suggested	suggest	I-VP	VBN	O	37	VC	O
O	O	266	267	,	,	O	,	O	42	P	O
O	O	268	270	no	no	B-NP	DT	O	41	NMOD	O
O	O	271	276	study	study	I-NP	NN	O	42	SUB	O
O	O	277	280	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	281	289	reported	report	I-VP	VBN	O	42	VC	O
O	O	290	297	whether	whether	B-SBAR	IN	O	43	VMOD	O
O	O	298	301	EBV	EBV	B-NP	NN	O	46	NMOD	O
O	O	302	311	infection	infection	I-NP	NN	O	47	SUB	O
O	O	312	314	is	be	B-VP	VBZ	O	44	SBAR	O
O	O	315	323	directly	directly	I-VP	RB	O	47	VMOD	O
O	O	324	330	linked	link	I-VP	VBN	O	47	VC	O
O	O	331	333	to	to	B-PP	TO	O	49	VMOD	O
T13	B-Entity	334	336	IL	IL	B-NP	NN	B-protein	54	NMOD	B-protein
T13	I-Entity	336	337	-	-	O	HYPH	I-protein	54	NMOD	I-protein
T13	I-Entity	337	339	12	12	B-NP	CD	I-protein	54	NMOD	I-protein
O	O	340	350	expression	expression	I-NP	NN	O	50	PMOD	O
O	O	350	351	.	.	O	.	O	42	P	O

O	O	352	354	To	To	B-VP	TO	O	2	VMOD	O
O	O	355	362	address	address	I-VP	VB	O	7	VMOD	O
O	O	363	367	this	this	B-NP	DT	O	4	NMOD	O
O	O	368	373	issue	issue	I-NP	NN	O	2	OBJ	O
O	O	373	374	,	,	O	,	O	7	P	O
O	O	375	377	we	we	B-NP	PRP	O	7	SUB	O
O	O	378	382	have	have	B-VP	VBP	O	0	ROOT	O
O	O	383	395	investigated	investigate	I-VP	VBN	O	7	VC	O
T14	B-Entity	396	398	IL	IL	B-NP	NN	B-protein	12	NMOD	B-protein
T14	I-Entity	398	399	-	-	O	HYPH	I-protein	12	NMOD	I-protein
T14	I-Entity	399	401	12	12	B-NP	CD	I-protein	12	NMOD	I-protein
O	O	402	412	expression	expression	I-NP	NN	O	8	OBJ	O
O	O	413	415	in	in	B-PP	IN	O	12	NMOD	O
O	O	416	417	B	B	B-NP	NN	B-cell_type	15	NMOD	B-cell_type
O	O	418	423	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	424	430	during	during	B-PP	IN	O	8	VMOD	O
O	O	431	433	in	in	B-NP	FW	O	18	AMOD	O
O	O	434	439	vitro	vitro	I-NP	FW	O	19	NMOD	O
O	O	440	454	transformation	transformation	I-NP	NN	O	16	PMOD	O
O	O	455	459	with	with	B-PP	IN	O	19	NMOD	O
O	O	460	463	EBV	EBV	B-NP	NN	O	20	PMOD	O
O	O	463	464	.	.	O	.	O	7	P	O

O	O	465	470	Human	Human	B-NP	JJ	B-cell_type	4	NMOD	B-cell_type
O	O	471	481	peripheral	peripheral	I-NP	JJ	I-cell_type	4	NMOD	I-cell_type
O	O	482	483	B	B	I-NP	NN	I-cell_type	4	NMOD	I-cell_type
O	O	484	489	cells	cell	I-NP	NNS	I-cell_type	5	SUB	I-cell_type
O	O	490	496	became	become	B-VP	VBD	O	0	ROOT	O
O	O	497	504	capable	capable	B-ADJP	JJ	O	5	PRD	O
O	O	505	507	of	of	B-PP	IN	O	6	AMOD	O
O	O	508	522	constitutively	constitutively	B-VP	RB	O	9	VMOD	O
O	O	523	532	producing	produce	I-VP	VBG	O	7	PMOD	O
T1	B-Protein	533	536	p40	p40	B-NP	NN	B-protein	9	OBJ	B-protein
O	O	537	539	by	by	B-PP	IN	O	9	VMOD	O
O	O	540	542	in	in	B-NP	FW	O	13	AMOD	O
O	O	543	548	vitro	vitro	I-NP	FW	O	14	NMOD	O
O	O	549	563	transformation	transformation	I-NP	NN	O	11	PMOD	O
O	O	564	568	with	with	B-PP	IN	O	14	NMOD	O
O	O	569	572	EBV	EBV	B-NP	NN	O	15	PMOD	O
O	O	572	573	,	,	O	,	O	6	P	O
O	O	574	584	coincident	coincident	B-ADJP	JJ	O	6	AMOD	O
O	O	585	589	with	with	B-PP	IN	O	18	AMOD	O
O	O	590	593	the	the	B-NP	DT	O	21	NMOD	O
O	O	594	604	expression	expression	I-NP	NN	O	19	PMOD	O
O	O	605	607	of	of	B-PP	IN	O	21	NMOD	O
T2	B-Protein	608	614	latent	latent	B-NP	JJ	B-protein	25	NMOD	B-protein
T2	I-Protein	615	623	membrane	membrane	I-NP	NN	I-protein	25	NMOD	I-protein
T2	I-Protein	624	631	protein	protein	I-NP	NN	I-protein	22	PMOD	I-protein
T2	I-Protein	632	633	1	1	I-NP	CD	I-protein	25	NMOD	I-protein
O	O	634	635	(	(	O	(	O	29	DEP	O
T3	B-Protein	635	639	LMP1	LMP1	B-NP	NN	B-protein	29	DEP	B-protein
O	O	639	640	)	)	O	)	O	25	NMOD	O
O	O	641	643	of	of	B-PP	IN	O	25	NMOD	O
O	O	644	647	EBV	EBV	B-NP	NN	O	30	PMOD	O
O	O	647	648	.	.	O	.	O	5	P	O

O	O	649	654	These	These	B-NP	DT	O	3	NMOD	O
O	O	655	656	B	B	I-NP	NN	B-cell_type	3	NMOD	B-cell_type
O	O	657	662	cells	cell	I-NP	NNS	I-cell_type	4	SUB	I-cell_type
O	O	663	672	expressed	express	B-VP	VBD	O	19	VMOD	O
T4	B-Protein	673	676	p40	p40	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	677	680	and	and	I-NP	CC	O	8	NMOD	O
T5	B-Protein	681	684	p35	p35	I-NP	NN	B-RNA	8	NMOD	B-RNA
O	O	685	689	mRNA	mRNA	I-NP	NN	I-RNA	4	OBJ	I-RNA
O	O	689	690	,	,	O	,	O	17	P	O
O	O	691	694	and	and	O	CC	O	13	NMOD	O
O	O	695	702	phorbol	phorbol	B-NP	NN	O	13	NMOD	O
O	O	703	712	myristate	myristate	I-NP	NN	O	13	NMOD	O
O	O	713	720	acetate	acetate	I-NP	NN	O	17	NMOD	O
O	O	721	722	(	(	O	(	O	16	DEP	O
O	O	722	725	PMA	PMA	B-NP	NN	O	16	DEP	O
O	O	725	726	)	)	O	)	O	13	NMOD	O
O	O	727	738	stimulation	stimulation	B-NP	NN	O	4	OBJ	O
O	O	739	747	strongly	strongly	B-ADVP	RB	O	19	VMOD	O
O	O	748	756	enhanced	enhance	B-VP	VBD	O	0	ROOT	O
T6	B-Protein	757	760	p40	p40	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	761	764	and	and	O	CC	O	23	NMOD	O
T15	B-Entity	765	768	p70	p70	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	769	779	production	production	I-NP	NN	O	19	OBJ	O
O	O	779	780	.	.	O	.	O	19	P	O

O	O	781	792	Furthermore	Furthermore	B-ADVP	RB	O	18	VMOD	O
O	O	792	793	,	,	O	,	O	18	P	O
O	O	794	806	transfection	transfection	B-NP	NN	O	18	SUB	O
O	O	807	811	with	with	B-PP	IN	O	3	NMOD	O
T7	B-Protein	812	816	LMP1	LMP1	B-NP	NN	B-DNA	7	NMOD	B-DNA
O	O	817	827	expression	expression	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	828	834	vector	vector	I-NP	NN	I-DNA	4	PMOD	I-DNA
O	O	835	839	into	into	B-PP	IN	O	3	NMOD	O
O	O	840	841	a	a	B-NP	DT	O	14	NMOD	O
O	O	842	847	human	human	I-NP	JJ	B-cell_line	14	NMOD	B-cell_line
O	O	848	849	B	B	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	850	858	lymphoma	lymphoma	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	859	863	cell	cell	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	864	868	line	line	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	868	869	,	,	O	,	O	16	P	O
O	O	870	875	Daudi	Daudi	B-NP	NNP	B-cell_line	8	PMOD	B-cell_line
O	O	875	876	,	,	O	,	O	16	P	O
O	O	877	880	led	lead	B-VP	VBD	O	0	ROOT	O
O	O	881	883	to	to	B-PP	TO	O	18	VMOD	O
T8	B-Protein	884	887	p40	p40	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	888	898	production	production	I-NP	NN	O	19	PMOD	O
O	O	899	903	with	with	B-PP	IN	O	21	NMOD	O
T16	B-Entity	904	911	nuclear	nuclear	B-NP	JJ	B-protein	30	NMOD	B-protein
T16	I-Entity	912	918	factor	factor	I-NP	NN	I-protein	30	NMOD	I-protein
T16	I-Entity	919	920	(	(	O	(	I-protein	30	NMOD	I-protein
T16	I-Entity	920	922	NF	NF	B-NP	NN	I-protein	30	NMOD	I-protein
T16	I-Entity	922	923	)	)	O	)	I-protein	30	NMOD	I-protein
T16	I-Entity	923	924	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T16	I-Entity	924	930	kappaB	kappaB	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	931	941	activation	activation	I-NP	NN	O	22	PMOD	O
O	O	941	942	.	.	O	.	O	18	P	O

O	O	943	948	These	These	B-NP	DT	O	2	NMOD	O
O	O	949	956	results	result	I-NP	NNS	O	3	SUB	O
O	O	957	964	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	965	969	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	970	984	transformation	transformation	B-NP	NN	O	12	SUB	O
O	O	985	987	of	of	B-PP	IN	O	5	NMOD	O
O	O	988	995	primary	primary	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	996	997	B	B	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	998	1003	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	1004	1008	with	with	B-PP	IN	O	5	NMOD	O
O	O	1009	1012	EBV	EBV	B-NP	NN	O	10	PMOD	O
O	O	1013	1020	induces	induce	B-VP	VBZ	O	4	SBAR	O
T17	B-Entity	1021	1023	IL	IL	B-NP	NN	B-protein	16	NMOD	B-protein
T17	I-Entity	1023	1024	-	-	O	HYPH	I-protein	16	NMOD	I-protein
T17	I-Entity	1024	1026	12	12	B-NP	CD	I-protein	16	NMOD	I-protein
O	O	1027	1037	expression	expression	I-NP	NN	O	12	OBJ	O
O	O	1038	1049	potentially	potentially	B-ADVP	RB	O	12	VMOD	O
O	O	1050	1057	through	through	B-PP	IN	O	12	VMOD	O
T9	B-Protein	1058	1062	LMP1	LMP1	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	1063	1073	expression	expression	I-NP	NN	O	18	PMOD	O
O	O	1073	1074	.	.	O	.	O	3	P	O

O	O	1075	1084	Copyright	Copyright	B-NP	NN	O	4	NMOD	O
O	O	1085	1089	1998	1998	I-NP	CD	O	4	NMOD	O
O	O	1090	1098	Academic	Academic	I-NP	NNP	O	4	NMOD	O
O	O	1099	1104	Press	Press	I-NP	NNP	O	0	ROOT	O
O	O	1104	1105	.	.	O	.	O	4	P	O
